Evidence map›Paper›PMID 39760837›Full record

ArticleJournal of racial and ethnic health disparities2026

Assessing Non-Oral PrEP Alternatives Among Young Black Women in the Southern USA.

Damian J Denson, Casey Langer Tesfaye, Daniela Glusberg, Alisú Schoua-Glusberg, Valerie Betley, Bryan Gale, Jessica Cardo, Paula M Frew, Eleanor McLellan-Lemal, Siobhán M O'Connor and 1 more

Abstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Damian J DensonDivision of HIV Prevention, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE, Mailstop US8-4, Atlanta, GA, 30333, USA. ddenson1@cdc.gov.ORCID 0000-0002-1643-4634
Casey Langer TesfayeResearch Support Services, Inc., Evanston, USA.
Daniela GlusbergResearch Support Services, Inc., Evanston, USA.
Alisú Schoua-GlusbergResearch Support Services, Inc., Evanston, USA.
Valerie BetleyAmerican Institutes for Research, Arlington, USA.
Bryan GaleAmerican Institutes for Research, Arlington, USA.
Jessica CardoResearch Support Services, Inc., Evanston, USA.
Paula M FrewDivision of Infectious Diseases Emory University School of Medicine Atlanta, Atlanta, USA.
Eleanor McLellan-LemalDivision of HIV Prevention, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE, Mailstop US8-4, Atlanta, GA, 30333, USA.
Siobhán M O'ConnorDivision of HIV Prevention, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE, Mailstop US8-4, Atlanta, GA, 30333, USA.
Janet M McNichollDivision of HIV Prevention, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE, Mailstop US8-4, Atlanta, GA, 30333, USA.

Funding

Intramural CDC HHS CC999999National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 200-2013-57341
6 · The paper itself

Abstract

Young Black women in the southern US face a high HIV burden. While daily oral HIV pre-exposure prophylaxis (PrEP) can effectively prevent HIV, its use is low among Black women. The acceptability of and perceived intention to use emerging PrEP products among young Black women in the southern US are not well understood. Non-oral PrEP alternatives could address challenges to PrEP uptake and reduce health disparities. We conducted virtual semi-structured interviews with Black women aged 18-34 in Atlanta, GA; Baton Rouge, LA; and Jackson, MS, to explore their perspectives on three emerging PrEP products: a long-acting injection, a subdermal implant, and a dual-purpose contraception and HIV prevention intravaginal ring. Seventy-five interviews were conducted from January to October 2021 and analyzed using inductive thematic analysis with NVivo software. Most participants were open to using medication to prevent HIV. The intravaginal ring was the most preferred, primarily due to its dual-purpose function, although it was also frequently rejected. The long-acting injection was the second most preferred and least rejected, perceived as the least invasive. The skin implant was the least preferred and most rejected, viewed as the most invasive. Our findings highlight the need for multiple PrEP options to meet individual preferences. Detailed descriptions, instructions, and experiential learning methods are crucial for choosing non-oral PrEP modalities. Practitioners should address questions and offer peer-based learning opportunities. Designing and promoting PrEP strategies for young Black women should involve close consultation with these consumers.

Indexed as

Black or African AmericanHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultFemaleHumansInterviews as TopicYoung AdultBlack womenHealth disparitiesHIV PreventionPrEPQualitative

Identifiers

PMID39760837
PMCPMC12228822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.